Intellia Therapeutics Inc sell The Goldman Sachs Group, Inc.
Start price
28.02.25
/
50%
€9.21
Target price
28.02.26
€8.65
Performance (%)
19.35%
End price
01.03.26
€10.99
Summary
This prediction ended on 01.03.26 with a price of €10.99. The SELL prediction by The_Goldman_Sachs_Gr finished with a performance of 19.35%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -4.872% | -4.872% | 29.088% |
| iShares Core DAX® | -3.509% | -8.747% | -0.997% |
| iShares Nasdaq 100 | -2.782% | -0.632% | 14.223% |
| iShares Nikkei 225® | -2.038% | -6.841% | 24.866% |
| iShares S&P 500 | -2.598% | -2.230% | 9.200% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "sell" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $9.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten